This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Kinetek Pharmaceuticals, Inc., Olt Inc.. Active years: 2003-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2007
Title: Greg Chopiuk: Innovator in Tumor Growth Inhibition
Introduction
Greg Chopiuk is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of cancer research, particularly in the development of methods to inhibit tumor growth. With a total of 2 patents to his name, Chopiuk's work is recognized for its potential impact on cancer treatment.
Latest Patents
Among his latest patents is a groundbreaking method titled "Heteropolycyclic inhibitors of protein kinases." This patent outlines a method of inhibiting tumor growth by administering an effective dose of a specific compound. His innovative approach aims to provide new avenues for cancer therapy.
Career Highlights
Throughout his career, Greg Chopiuk has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with Kinetek Pharmaceuticals, Inc. and Olt Inc. These experiences have allowed him to apply his expertise in a practical setting, contributing to advancements in medical science.
Collaborations
Chopiuk has collaborated with talented individuals in his field, including Zaihui Zhang and Xinyao Du. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in cancer treatment.
Conclusion
Greg Chopiuk's contributions to the field of cancer research through his patents and collaborations highlight his commitment to innovation. His work continues to inspire advancements in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile